Skip to Content
Merck
CN
All Photos(1)

Documents

Safety Information

15-1370

Sigma-Aldrich

Iron(II) oxide

CP

Sign Into View Organizational & Contract Pricing

Empirical Formula (Hill Notation):
FeO
CAS Number:
Molecular Weight:
71.84
MDL number:
UNSPSC Code:
12352300
PubChem Substance ID:

grade

CP

form

solid

availability

available only in Japan

density

5.7 g/mL at 25 °C (lit.)

storage temp.

15-25°C

SMILES string

O=[Fe]

InChI

1S/Fe.O

InChI key

UQSXHKLRYXJYBZ-UHFFFAOYSA-N

Looking for similar products? Visit Product Comparison Guide

WGK

nwg

Flash Point(F)

Not applicable

Flash Point(C)

Not applicable

Regulatory Information

新产品

Certificates of Analysis (COA)

Search for Certificates of Analysis (COA) by entering the products Lot/Batch Number. Lot and Batch Numbers can be found on a product’s label following the words ‘Lot’ or ‘Batch’.

Already Own This Product?

Find documentation for the products that you have recently purchased in the Document Library.

Visit the Document Library

Hoang Tri Hai et al.
Journal of colloid and interface science, 346(1), 37-42 (2010-03-12)
Monodisperse wustite (core)/spinel (shell) nanocubes with controllable size from 9 to 22 nm were synthesized by the decomposition of iron oleate complex at high temperature. The composition of the nanocubes was confirmed by X-ray diffraction and magnetic analysis, meanwhile the
Xiaolian Sun et al.
Nano letters, 12(1), 246-251 (2011-12-03)
Monodisperse 35 nm FeO nanoparticles (NPs) were synthesized and oxidized in a dry air atmosphere into core/shell FeO/Fe(3)O(4) NPs with both FeO core and Fe(3)O(4) shell dimensions controlled by reaction temperature and time. Temperature-dependent magnetic properties were studied on FeO/Fe(3)O(4)
Gen Zhang et al.
Cancer science, 102(6), 1216-1222 (2011-03-26)
10-Hydroxycamptothecin (HCPT) elicits strong anti-cancer effects and is less toxic than camptothecin (CPT), making it widely used in recent clinical trials. However, its low solubility limits its application as an effective anti-cancer therapy. In the present study we investigate the
Xi Zou et al.
ACS nano, 6(10), 8997-9004 (2012-09-14)
Fatigue in ferroelectric oxides has been a long lasting research topic since the development of ferroelectric memory in the late 1980s. Over the years, different models have been proposed to explain the fatigue phenomena. However, there is still debate on
Gen Zhang et al.
Nanomedicine : nanotechnology, biology, and medicine, 7(5), 595-603 (2011-02-22)
Nanomaterials can enhance the delivery and treatment efficiency of anticancer drugs, but the mechanisms of the tumor-reducing activity of ferrous-ferric oxide (Fe(3)O(4)) nanoparticles (NPs) with daunorubicin (DNR) have not been established. Here we investigate the synergistic effects of Fe(3)O(4) NPs

Our team of scientists has experience in all areas of research including Life Science, Material Science, Chemical Synthesis, Chromatography, Analytical and many others.

Contact Technical Service